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ABSTRACT Zika virus (ZIKV) is an emerging flavivirus, mainly transmitted by mosqui-
toes, which represents a global health threat. A common feature of flavivirus-infected
cells is the accumulation of viral noncoding subgenomic RNAs by partial degradation of
the viral genome, known as sfRNAs, involved in immune evasion and pathogenesis. Al-
though great effort is being made to understand the mechanism by which these sfRNAs
function during infection, the picture of how they work is still incomplete. In this study,
we developed new genetic tools to dissect the functions of ZIKV RNA structures for viral
replication and sfRNA production in mosquito and human hosts. ZIKV infections mostly
accumulate two kinds of sfRNAs, sfRNA1 and sfRNA2, by stalling genome degradation
upstream of duplicated stem loops (SLI and SLII) of the viral 3= untranslated region
(UTR). Although the two SLs share conserved sequences and structures, different func-
tions have been found for ZIKV replication in human and mosquito cells. While both SLs
are enhancers for viral infection in human cells, they play opposite roles in the mosquito
host. The dissection of determinants for sfRNA formation indicated a strong cooperativ-
ity between SLI and SLII, supporting a high-order organization of this region of the 3=
UTR. Using recombinant ZIKV with different SLI and SLII arrangements, which produce
different types of sfRNAs or lack the ability to generate these molecules, revealed that at
least one sfRNA was necessary for efficient infection and transmission in Aedes aegypti
mosquitoes. Importantly, we demonstrate an absolute requirement of sfRNAs for ZIKV
propagation in human cells. In this regard, viruses lacking sfRNAs, constructed by dele-
tion of the region containing SLI and SLII, were able to infect human cells but the infec-
tion was rapidly cleared by antiviral responses. Our findings are unique for ZIKV, since in
previous studies, other flaviviruses with deletions of analogous regions of the genome,
including dengue and West Nile viruses, accumulated distinct species of sfRNAs and
were infectious in human cells. We conclude that flaviviruses share common strategies
for sfRNA generation, but they have evolved mechanisms to produce different kinds of
these RNAs to accomplish virus-specific functions.
IMPORTANCE Flaviviruses are important emerging and reemerging human patho-
gens. Understanding the molecular mechanisms for viral replication and evasion of
host antiviral responses is relevant to development of control strategies. Flavivirus
infections produce viral noncoding RNAs, known as sfRNAs, involved in viral replica-
tion and pathogenesis. In this study, we dissected molecular determinants for Zika
virus sfRNA generation in the two natural hosts, human cells and mosquitoes. We
found that two RNA structures of the viral 3= UTR operate in a cooperative manner
to produce two species of sfRNAs and that the deletion of these elements has a
profoundly different impact on viral replication in the two hosts. Generation of at
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least one sfRNA was necessary for efficient Zika virus infection of Aedes aegypti mos-
quitoes. Moreover, recombinant viruses with different 3= UTR arrangements revealed
an essential role of sfRNAs for productive infection in human cells. In summary, we
define molecular requirements for Zika virus sfRNA accumulation and provide new
ideas of how flavivirus RNA structures have evolved to succeed in different hosts.
KEYWORDS Zika virus, flavivirus, noncoding RNAs, sfRNAs
The explosive epidemic of Zika virus (ZIKV) in 2016, together with the uniqueproperties of this virus regarding transmission and disease, posed a tremendous
challenge to understand its mechanisms of infection and pathogenesis (1). Due to the
late appearance of symptoms in newborns from infected mothers, the dimension of the
damage caused by this virus in the last few years is still unknown (2). ZIKV is an
enveloped, plus-stranded RNA virus and is a member of the flavivirus genus, together
with a number of important human pathogens, including dengue virus (DENV), West
Nile virus (WNV), yellow fever virus (YFV), and Japanese encephalitis virus (JEV). The
genomic RNA encodes the viral proteins but also contains a great deal of information
in RNA structures present in both the translated region and the untranslated region
(UTR). These RNA elements have important functions in viral translation, genome
replication, immune evasion, host adaptation, and pathogenesis (for reviews, see
references 3 and 4). However, understanding of the molecular mechanism by which the
viral RNA elements regulate these processes is still incomplete.
The ZIKV genome is 11 kb, containing 5= and 3= UTRs of about 107 and 428
nucleotides, respectively. The 5= UTR has a large Y-shaped stem-loop structure (SLA),
similar to that observed in other flaviviruses, which functions as a promoter for viral
polymerase binding (5). This promoter is followed by a cyclization sequence known as
the 5= UAR (upstream AUG region) that mediates long-range RNA-RNA interactions (6).
Additional flavivirus cyclization sequences are located in the coding region of the
capsid protein, known as DAR (downstream AUG region), CS1 (conserved sequence 1),
and C1 in the case of DENV (7–11). These elements interact with complementary
regions present at the viral 3= UTR, including 3= UAR, 3= DAR, and 3= CS, respectively.
The 3= UTRs of flaviviruses contain RNA structures that are different in distinct ecolog-
ical or phylogenetic groups but that all share a small hairpin 3= stem-loop (sHP-3= SL)
at the genome end (4, 12). According to the hosts that they infect, flaviviruses are
divided into four groups: mosquito borne (MBFV), tick borne (TBFV), viruses that infect
mammals with no known vector (NKVFV), and viruses that are insect specific (ISFV).
The 3= UTRs of MBFV include duplications of complex RNA structures known as stem
loops and dumbbells (DBs) (4). The ZIKV 3= UTR carries conserved duplicated SLs (SLI
and SLII) but bears a single DB element preceded by a unique RNA structure, absent in
most MBVF, named pseudo-DB (DB). SLs and DBs contain conserved sequences and
structures, including stabilizing pseudoknot (PK) interactions. The compact folding of
these RNA elements forms units that are known as XRN1-resistant structures (xrRNAs),
due to their ability to stall exoribonuclease degradation during viral genome decay (13).
This process results in the accumulation of noncoding subgenomic flavivirus RNAs
(sfRNAs) (14–16). The structural details by which the SLs block XRN1 activity were
elucidated by crystal structures of SLs from Murray Valley encephalitis virus (MVEV) and
ZIKV (17, 18). These studies revealed a common knot-like fold of the SL that impairs
XRN1 activity. DB structures also stall XRN1 when SLs are mutated or, in the case of
DENV, when the virus is adapted to mosquitoes (19, 20). However, the mechanism by
which DB structures block exoribonuclease-dependent degradation of the genome is
still unknown.
Accumulation of sfRNAs in flavivirus infections has been shown to be implicated in
viral replication, cytopathicity, and pathogenesis (14, 21–24). It has been demonstrated
that sfRNAs modulate host responses against flaviviruses in humans and mosquitoes
(23, 25–28). Different studies support the idea that sfRNAs act as sponges, sequestering
RNA binding proteins important in antiviral responses, dysregulating cellular mRNA
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decay, and modulating host RNA splicing (29–32). However, the mechanisms by which
these viral molecules function during flavivirus infections are still under intensive
investigation (for review, see reference 33). It is important to highlight that each
flavivirus produces different amounts, sizes, and numbers of sfRNAs, and the factors
modulating these differences are still unclear. It is likely that different selective pres-
sures during flavivirus evolution led to fine-tuning of the quality of sfRNAs produced by
each virus depending on different antiviral responses in distinct host species, viral
tropism, or other viral requirements. For instance, although DENV and ZIKV are both
MBFVs and conserve two SL structures at their 3= UTRs, DENV infection mainly accu-
mulates a single sfRNA, while ZIKV predominantly produces two types of these mole-
cules (18, 20). Moreover, accumulation of different amounts of sfRNAs during infection
has been associated with distinct epidemiological fitness of DENV isolates (32), indi-
cating the relevance and complexity of sfRNA functions in flavivirus infections.
In this study, we investigated molecular determinants and specific requirements for
sfRNA accumulation during ZIKV infection in different hosts. To this end, we generated
new infectious ZIKV clones and reporter viruses from local Argentinean isolates. Re-
combinant ZIKV with different 3= UTR arrangements revealed strong cooperativity
between SLI and SLII for sfRNA generation. Mutations or deletions of SLII abolished SLI
exoribonuclease stalling function. In addition, ZIKV mutants that produce different
types and amounts of sfRNAs revealed host-specific requirements for infection and viral
propagation. The generation of at least one sfRNA was necessary for the virus to
maintain the natural capacity to overcome the midgut and salivary gland barriers of
Aedes aegypti mosquitoes. ZIKV lacking SLI produced large amounts of a single sfRNA,
and the virus replicated in mosquito cells about 50-fold more than WT ZIKV. This virus
was efficient in infecting mosquitoes, while infection in human cells was reduced.
Interestingly, recombinant viruses lacking the ability to produce sfRNAs, which grow
efficiently in mosquito cells, were unproductive in human cells. In summary, this work
identifies molecular determinants for ZIKV sfRNA generation and demonstrates the
essential role of sfRNAs for ZIKV productive infection in human cells.
RESULTS
Construction of epidemic and nonepidemic full-length ZIKV cDNA clones. A
ZIKV isolate from Argentina (epidemic virus; GenBank accession no. MT636065) was
amplified in Vero cells, sequenced, and used as the template to construct a cDNA clone.
The full genome was divided into 6 fragments (Fig. 1A). Each fragment (F1 to F6) was
amplified by reverse transcription-PCR (RT-PCR) and individually cloned into a medium-
copy-number vector, except for F2. The plasmid containing fragment F2 was consis-
tently rescued with mutations and deletions, indicating the unstable nature of this
sequence in bacteria. The mutations identified, spanning nucleotides 1859 to1899 at
the envelope protein-coding sequence, disrupted the open reading frame (ORF),
suggesting the presence of a cryptic promoter(s) and translation of toxic viral se-
quences in Escherichia coli. This problem has been previously reported for ZIKV and
other flaviviruses (34, 35). Three different algorithms that predict cryptic promoters in
bacteria supported the presence of such sequences in F2 (Fig. 1A). Based on this
information, synonymous mutations were incorporated to disrupt the promoter. These
changes were sufficient to obtain a stable F2 fragment. The complete cDNA sequence
of ZIKV was then assembled in a medium-copy-number plasmid by sequential incor-
poration of the different fragments to obtain pZIKVAr.
Using a similar strategy, a second infectious clone from a laboratory-adapted ZIKV
from Senegal (nonepidemic virus; GenBank accession no. KX198134) was constructed.
The full-length genome was also divided into 6 fragments (Fig. 1B). Each fragment was
cloned individually, without unstable sequences in E. coli. Thus, they were directly
assembled into a medium-copy-number plasmid to obtain pZIKVSe. The stability of
pZIKVAr and pZIKVSe plasmids was assessed by 5 successive transformations in bacteria
and plasmid preparation.
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To examine infectivity, T7 RNA transcripts from pZIKVAr and pZIKVSe were obtained
and transfected into mosquito and human cells. RNAs were infectious, and viruses
propagated in both cell types, showing profound cytopathic effect after 4 and 3 days,
respectively (Fig. 1C). In addition, both viruses produced plaques that were more
homogeneous with the cloned viruses than the original isolates (Fig. 1D). Titers
between 107 and 108 PFU/ml were obtained from both infectious clones. ZIKVSe
showed larger plaques than ZIKVAr (Fig. 1D). Viral stocks obtained from both infectious
clones were used to infect A. aegypti mosquitoes. A blood meal with final titer of
1  106 PFU/ml was used. Both viruses showed high rate of infectivity in mosquitoes
(between 80 and 100%), and both reached saliva (Fig. 1E). We conclude that the two
infectious clones are suitable tools to study molecular aspects of ZIKV biology.
In order to dissect functions of viral RNA structures relevant for sfRNA formation,
full-length ZIKV reporters carrying the luciferase gene were constructed from the
infectious clones. To this end, we introduced the Renilla luciferase coding sequence
flanked by foot and mouth disease virus (FMDV) 2A sites, followed by the complete viral
open reading frame. In addition, viral cis-acting replication sequences present in the
capsid protein coding region were included upstream of the luciferase to ensure
FIG 1 Design and characterization of full-length ZIKV infectious clones. (A) Representation of the strategy
used for assembling a ZIKV cDNA clone from an Argentinean isolate (pZIKVAr). Restriction sites used to clone
each fragment are indicated on the top. Below this schematic are shown the sequences of predicted
prokaryotic promoters (red) responsible for instability in bacteria. Synonymous mutations incorporated are
indicated in green. (B) Representation of the strategy used for assembling a ZIKV cDNA clone from a
laboratory-adapted virus obtained from Senegal (pZIKVSe). (C) Transfections of viral RNAs generated by in
vitro transcription are infectious in mosquito and human cells, as shown by immunofluorescence using
antibodies against ZIKV NS3 protein. CPE, cytopathic effect. (D) The rescued ZIKVAr and ZIKVSen are
infectious and form plaques in BHK cells. (E) Infection and transmission rates of the cloned viruses in A.
Aegypti mosquitoes are shown. Female mosquitoes were fed with an infectious blood meal containing
1  106 FFU/ml of ZIKVAr or ZIKVSen.
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efficient viral RNA replication (Fig. 2A). For each ZIKV reporter construct, a replication-
impaired control was constructed by mutation of the GDD catalytic site of the NS5
polymerase domain (NS5 M). Transfection of transcribed RNA corresponding to epi-
demic (ZIKVAr-R) and nonepidemic (ZIKVSe-R) ZIKV reporters resulted in viral replica-
tion in human and mosquito cells (Fig. 2B). The reporter viruses generated infectious
progeny retaining luciferase expression. Replication kinetics comparisons showed a
faster replication of ZIKVSe-R than of the epidemic ZIKVAr-R in both cell types (Fig. 2B).
A dynamic range of at least 3 orders of magnitude was observed when the wild type
(WT) and NS5 M replication-impaired control were compared (Fig. 2B).
Inverted locations of SLI and SLII in DENV and ZIKV 3= UTRs are associated with
function. The two SL structures present at the viral 3= UTR have been directly involved
in the generation of sfRNAs for different MBFVs and in host adaptation in DENV. In the
case of ZIKV infections, two main species of sfRNAs (sfRNA1 and sfRNA2) are produced
in cell culture and A. aegypti mosquitoes, which are associated with xrRNA1 structure
FIG 2 Design and construction of ZIKV reporter systems. (A) Schematic representation of ZIKV reporter system carrying the luciferase gene flanked by FMDV
2A sequences. The predicted RNA structures in the 3= UTR, including stem loops I and II (SLI and SLII), pseudodumbbell DB, dumbbell DB, and a small hairpin
3= stem-loop (sHP-3= SL), are indicated. (B) Reporter ZIKVs efficiently translate and replicate in mosquito and human cells. Luciferase expression levels of ZIKVAr-R
and ZIKVSen-R are shown as a function of the time. Luciferase activity was measured in transfected cells with viral RNAs corresponding to WT and
replication-impaired NS5 M. The luciferase values are means  standard deviations (representative experiment of three independent experiments). hpt, hours
posttransfection.
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(including SLI and downstream hairpin) and xrRNA2 structure (including SLII and
downstream hairpin), respectively (Fig. 3A). However, the role of the SL elements in
ZIKV infection and sfRNA generation has not been systematically examined. We have
previously studied functions of DENV SLI and SLII and found that they play opposite
roles in infected mosquitoes, but have redundant functions in infected human cells (20,
36). Although SLI and SLII share structural elements and sequences among different
MBFVs, comparison of key structural features critical for xrRNA function within these
structures from DENV and ZIKV suggested that their locations may be inverted (Fig. 3B).
In this regard, ZIKV SLI resembles DENV SLII, and ZIKV SLII bears sequence and structure
similar to those of DENV SLI.
To examine the possible inversion of the SLs in DENV and ZIKV, sequence and
structural comparisons between SLs from different flaviviruses were performed (Fig. 3C
and D). Both studies indicated that ZIKV SLs are closer to DENV SLs than to SLs of other
flaviviruses. Secondary RNA structure similarity analyses were made for different flavi-
virus SLs with known structures and using the tree alignment model implemented in
the RNAforester software. This method allows determination of the relative similarity
between two models of secondary structures by estimating the number of changes
necessary to convert one structure to another. The available crystal structures of SLs
were used to guide the folding of other flavivirus SL structures (17, 18). The analysis
showed that both ZIKV SLs are structurally related to DENV2 SLs, and the ZIKV SLI was
clearly closer to DENV2 SLII (Fig. 3C). Moreover, by analyzing nucleotide sequence
similarities by MUSCLE and using Jalview software (37), the alignment shows that ZIKV
SLI is closer to DENV SLII and that ZIKV SLII is closer to DENV SLI (Fig. 3D). Based on
these observations, we hypothesized that their functions may also be inverted, and this
could be the reason why different types of sfRNAs are produced by the two viruses.
To evaluate the function of the ZIKV SLs, we constructed recombinant viruses in the
context of the reporter system lacking each of these elements (ZIKV-RΔSLI and ZIKV-
RΔSLII). In vitro-transcribed viral RNA from the WT and mutants were transfected in
human and mosquito cells. Transfections in human cells indicated that the lack of either
SLI or SLII reduced viral replication (Fig. 3E). The two mutant reporter viruses ZIKV-RΔSLI
and ZIKV-RΔSLII consistently replicated about 10-fold less than the ZIKV-R WT. In
contrast, when ZIKV-RΔSLI and ZIKV-RΔSLII RNAs were transfected into mosquito cells,
the SLs showed opposite effects on viral replication (Fig. 3E). While ZIKV-RΔSLII repli-
cated less than the ZIKV-RWT at 72 and 96 h, ZIKV-RΔSLI showed a great increase in
RNA amplification, about 50-fold more than the WT (Fig. 3E). The result obtained in this
experiment is the opposite of that previously reported with recombinant DENV (36). It
has been previously shown that SLII of DENV was subjected to sequence variations
during mosquito adaptation, and mutations in this element greatly increased viral
replication. In the case of ZIKV, the deletion of SLI displayed a higher replication
phenotype, suggesting functional similarities between SLI of ZIKV and SLII of DENV2
(Fig. 3F).
In conclusion, we found that ZIKV and DENV2 SLs evolved functionally equivalent
structures in inverted locations of their 3= UTRs, suggesting that SLI and SLII diverged
in each virus after duplication.
Dissecting functional determinants for ZIKV sfRNA generation reveals strong
cooperativity between the duplicated SL structures. To define RNA elements re-
quired for sfRNA accumulation during ZIKV infection, we studied which types of sfRNAs
are produced by viruses with different SL arrangements at the viral 3= UTR. Recombi-
nant viruses were designed in the context of the epidemic clone. First, we generated
ZIKVΔSLI, ZIKVΔSLII, and ZIKVΔSLI-II, lacking xrRNA1, xrRNA2, and both, respectively. In
vitro-transcribed RNA from these clones and the WT were transfected in C6/36 cells.
Immunofluorescence (IF) analysis as a function of time showed that ZIKVΔSLI replicated
faster than the WT, while ZIKVΔSLII and ZIKVΔSLI-II were slightly delayed (Fig. 4A). Total
RNAs from infected cells were used to evaluate genomic RNA and to examine the
quality of sfRNAs accumulated in each case. Northern blotting was performed with
samples harvested at 72 h for ZIKV WT and ZIKVΔSLI and at 96 h for ZIKVΔSLII and
Pallarés et al. Journal of Virology
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FIG 3 Distinct functions of duplicated stem-loop structures present at the ZIKV 3= UTR. (A) Schematic representation of ZIKV 3= UTR showing the two
XRN1-resistant RNAs involved in sfRNA formation (xrRNA1 and xrRNA2, including SLI and SLII, respectively). At the right are Northern blots showing the pattern
of sfRNAs generated during ZIKV infection in vertebrate and invertebrate cells and A. aegypti mosquitoes as indicated. The two main sfRNAs of 413 and 329
nucleotides are shown together with a minor sfRNA of about 240 nucleotides. (B) Comparison of secondary structures of duplicated SLs from ZIKV and DENV2
based on available biochemical probing and crystal structures. (C) Fan dendrogram indicating the distance between SL structures of the indicated
mosquito-borne flaviviruses (MBFVs). SLI and SLII of different MBFVs correspond to the structures included in xrRNA1 and xrRNA2, respectively, and their
locations (first and second) are with respect to the 5= end of the 3= UTR. (D) Phylogenetic analysis based on sequence alignments of SLs from different MBFVs.
(E) Distinct functions of the two SLs in human and mosquito cells, as indicated in each case. Replication of recombinant reporter ZIKV carrying deletions of
xrRNA1 (ΔSLI) or xrRNA2 (ΔSLII) is shown together with the WT and a replication-impaired control NS5 M as a function of time. The luciferase values are means 
standard deviations of a representative experiment (three independent experiments were performed). (F) Roles of SLI and SLII of ZIKV and DENV in viral
replication in the two hosts support inverted location of these two RNA elements.
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FIG 4 Dissecting the molecular determinants for ZIKV sfRNA accumulation. (A) Representative immunofluorescence
showing replication and propagation of ZIKV WT and recombinants carrying deletions of each SL or both SLs. (B) SLII plays
a central role in ZIKV sfRNA generation. Shown are Northern blots detecting genomic RNA (top) and sfRNAs (bottom) from
infected mosquito cells with the indicated recombinant ZIKVs. The size and mobility of different sfRNA species are
indicated on the left (sfRNA1 and -2). An sfRNA of 347 nucleotides in length generated by a ZIKV with SLII deletion (empty
(Continued on next page)
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ZIKVΔSLI-II. At the indicated times the amounts of genomic RNA, evaluated with a
probe hybridizing to viral 5= UTR sequences, were similar for WT, ΔSLII, and ΔSLI-II ZIKVs
but were consistently higher for the ZIKVΔSLI mutant (Fig. 4B), in agreement with the
increased RNA replication observed with the reporter virus (Fig. 3E). Extracts from ZIKV
WT-infected cells showed the accumulation of two species of sfRNAs, and the recom-
binant ZIKVΔSLI yielded only one species (sfRNA2) of 329 nucleotides in length (Fig. 4B).
sfRNA2 is the product of stalling XRN1 at the intact SLII structure of xrRNA2. However,
in infections with ZIKVΔSLII, which retains an intact SLI, sfRNAs were almost undetect-
able. A faint band consistent with the length of the sfRNA1 (carrying a deletion of SLII)
of 347 nucleotides was observed, suggesting insufficient strength of xrRNA1 alone to
stop exoribonuclease degradation (Fig. 4B). Furthermore, deletion of SLI-II abolished
production of sfRNAs (Fig. 4B). In this regard, it is important to mention that previous
studies with other flaviviruses, including DENV and WNV, lacking the homologous
SLI-SLII region, accumulated shorter sfRNA species (sfRNA3 and sfRNA4) by stalling
XRN1 at DB structures (13, 14, 19, 20, 38). Thus, ZIKVΔSLI-II appears to have different
properties.
In summary, we found that (i) an intact SLI was not sufficient to stop the exoribo-
nuclease activity in the absence of SLII, (ii) an intact SLII was sufficient to generate
sfRNA2, and (iii) sfRNA production was absent in viruses lacking both SLs (Fig. 4C).
The strong effect of deleting SLII on the function of SLI for ZIKV sfRNA formation
suggests a structural interaction between these two RNA elements. To confirm this, and
to rule out unpredicted structural alterations due to the deletions introduced in the
viral 3= UTR, we designed new recombinant viruses based on crystallographic studies of
flavivirus SLs (17, 18). It has been shown that nucleotides preceding the SLs base-pair
with nucleotides at the three-way junction, forming an internal pseudoknot (Fig. 4D).
Mutations were introduced upstream of SLI (UGU replaced by ACC) or SLII (AGU
replaced by CAC), impairing in each case formation of the internal PK, ZIKV5=mSLI and
ZIKV5=mSLII, respectively (Fig. 4D). These mutations were incorporated in both infec-
tious clones and reporter ZIKV-R.
Transfection of RNA from the ZIKV WT and mutants (ZIKV5=mSLI and ZIKV5=mSLII)
led to viral replication and propagation in C6/36 cells (Fig. 4E). Infection with
ZIKV5=mSLI resulted in the accumulation of a single sfRNA corresponding in size to
sfRNA2, indicating resistance to RNA degradation at SLII (Fig. 4E). ZIKV5=mSLII, holding
an intact SLI, generated a barely detectable sfRNA (413 nucleotides long). This pheno-
type was similar to that observed with the deletion of the complete SLII (ZIKVΔSLII
mutant). In this regard, the size difference observed in the detectable sfRNAs for
ZIKVΔSLII and ZIKV5=mSLII accounts for the deletion of the SLII (compare Fig. 4B and E).
These results show the requirement of a stable SLII structure for SLI function. We
conclude that the two SLs display strong cooperativity for sfRNA1 production, suggest-
ing a high-order organization of the RNA in this region of the 3= UTR.
To evaluate the replication properties of viruses carrying the 5=mSLI and 5=mSLII
substitutions, reporter ZIKV constructs were designed. RNAs corresponding to the WT,
the replication-impaired control, and the two mutants (ZIKV-R 5=mSLI and 5=mSLII)
were transfected into C6/36 mosquito and Huh-7 human cells, and reporter activity was
FIG 4 Legend (Continued)
circle) is indicated on the right. (C) Illustrative representation of the SLs as knots and the species of sfRNAs produced by
each virus. (D) Destabilization of SL structures alters sfRNA generation. Representation of mutants ZIKV5=mSLI and
ZIKV5=mSLII, indicating the location and nucleotide substitution in each case. (E) (Left) Replication of transfected
ZIKV5=mSLI and ZIKV5=mSLII RNAs in C6/36 cells shown by immunofluorescence. (Right) sfRNA pattern produced by ZIKV
WT, ZIKV5=mSLI, and ZIKV5=mSLII, as indicated. The empty circle indicates the sfRNA produced by the ZIKV5=mSLII of 413
nucleotides. (F and G) Replication of ZIKVAr-R carrying the 5=mSLI and 5=mSLII mutations in human and mosquito cells, as
indicated in each case, was assessed by measuring luciferase activity as a function of time. The luciferase values are
means  standard deviations from a representative experiment (three independent experiments were performed). (H)
(Left) Replication of ZIKVAr WT or ZIKVAr xrRNA inverted mutant at 3 and 4 days posttransfection, shown by immunoflu-
orescence. (Right) Northern blots showing genomic RNA (top) and sfRNAs (bottom) from infected mosquito cells with the
indicated recombinant ZIKVs (WT or xrRNAs inverted mutant). (I) Illustrative representation of xrRNAs for the WT and
mutant, highlighting the relevance of the location and cooperativity between the two SLs.
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evaluated as a function of time. The virus ZIKV-R 5=mSLI, which accumulated large
amounts of sfRNA2, showed a delayed RNA synthesis and about 10-fold-reduced
reporter activity in human cells (Fig. 4F). In contrast, the mutant ZIKV-R 5=mSLII, which
was sfRNA-impaired, displayed low levels of reporter activity, supporting an important
defect in replication of this virus (Fig. 4F). In mosquito cells, ZIKV-R 5=mSLI replicated
similarly to the WT, while the mutant ZIKV-R 5=mSLII showed a reduction of about
10-fold in reporter activity with respect to that of the WT (Fig. 4G). These results,
together with the information obtained with the recombinant and reporter viruses
lacking SLI, indicate that the increased fitness of ZIKVΔSLI (also included in Fig. 4G for
comparison) in mosquito cells was not due to the production of a single sfRNA
(sfRNA2); the ZIKV-R 5’mSLI produced the same sfRNA2 but replicated similarly to the
ZIKV-R WT (compare ZIKV-R 5=mSLI and ZIKVΔSLI).
To further assess whether location of the SLs determines the different qualities of
sfRNAs produced by DENV and ZIKV, or whether the interplay between these structures
requires specific locations for their function, we inverted their positions in the ZIKV 3=
UTR. To this end, the complete xrRNA2 structure (including SLII and downstream
hairpin [Fig. 3A]) was placed upstream of SLI. A virus with this 3= UTR rearrangement
was infectious, and viral propagation was readily detected in mosquito cells (Fig. 4H).
The genomic RNA of this recombinant virus was similar to that observed for the WT
virus; however, the amounts of sfRNA1 and -2 were largely reduced (Fig. 4F). This result
indicates that both SLs were inefficient to resist exoribonuclease degradation, confirm-
ing an interplay between the two structures in the WT arrangement (Fig. 4I).
In conclusion, we dissected functional elements responsible for ZIKV sfRNA forma-
tion. The data support a model in which the two SLs at the ZIKV 3= UTR function in a
cooperative manner to halt exoribonuclease activity. Importantly, we generated a
recombinant ZIKV that propagates in mosquito cells without producing detectable
sfRNAs.
ZIKV ability to generate sfRNAs is necessary for dual host infection. To further
study the properties of the virus that lacks sfRNA accumulation, we constructed the
reporter ZIKV-RΔSLI-II. Transfection of mutant, WT, or control viral RNA into insect cells
showed efficient translation and RNA replication of ZIKV-RΔSLI-II (Fig. 5A). The same
reporter virus showed impaired reporter activity in human cells (Fig. 5B), suggesting
differential requirements of sfRNAs in the two hosts. To confirm this observation,
infection and propagation properties of the ZIKVΔSLI-II in the context of the infectious
clone were evaluated. Immunofluorescence as a function of time after viral RNA
transfection showed efficient infection in C6/36 cells. Although ZIKVΔSLI-II showed
delayed propagation with respect to that of the WT, titers above 108 infectious particles
per ml, similar to those of the WT, were obtained (Fig. 5C). In contrast, no propagation
of ZIKVΔSLI-II was detected in transfected Huh-7 human cells. ZIKVΔSLI-II stocks were
generated in C6/36 cells, and since ZIKV does not produce plaques in these cells,
focus-forming units (FFU) were evaluated to quantify the virus (Fig. 5C). To examine if
the sfRNA-deficient virus was able to infect and propagate at low levels in human cells,
the virus produced in mosquito cells was used to infect A549 human cells. ZIKVΔSLI-II
infection was observed at 24 h by IF analysis. However, the viral antigen signal was
undetectable at 72 h postinfection (hpi) (Fig. 5D). This phenotype indicates the inability
of the mutant virus to sustain the infection in human cells. Together, the results show
different behaviors for ZIKV-RΔSLI-II for productive propagation in mosquito and
human cells.
It has been previously reported that the mosquito C6/36 cell line is Dicer 2 deficient;
thus, we hypothesized that this defect could be responsible for the permissiveness to
infection of these cells. To evaluate this, we analyzed the ability of ZIKVΔSLI-II to infect
the Dicer 2-competent U4.4 mosquito cells. In this regard, the ZIKVΔSLI-II was also able
to infect and propagate efficiently in U4.4 cells, as determined by IF analysis (Fig. 5D),
indicating that replication and propagation of ZIKVΔSLI-II are independent of the
function of Dicer-2.
Pallarés et al. Journal of Virology
September 2020 Volume 94 Issue 18 e00343-20 jvi.asm.org 10
 on A







We conclude that a deletion at the viral 3= UTR, which abrogates generation of
sfRNAs, results in a ZIKV that infects and propagates in mosquito cells but shows
profound defects in human cells.
A ZIKV that does not accumulate sfRNAs fails to control the antiviral response
in human cells. We identified a ZIKV with impaired sfRNA generation that propagated
in mosquito cells but was limited in human cells. Taking into account the role of sfRNAs,
we hypothesized that this virus was deficient in counteracting human antiviral re-
sponses. To study this possibility, we evaluated a time course of infection and the
consequent antiviral response induced by the sfRNA-deficient ZIKV and the WT ZIKV in
A549 cells. High-titer stocks of the WT and ZIKVΔSLI-II generated in mosquito cells were
used to avoid secondary infections or bystander cell responses (Fig. 6A). Under these
conditions, the complete monolayer was infected with both viruses at 24 hpi. However,
while the WT virus showed extensive cytopathic effect and cell death at 72 hpi, cells
infected with ZIKV ΔSLI-II were almost cured at this time (Fig. 6A). In this regard, positive
viral antigen by IF was observed scarcely, and the monolayer was intact, as shown by
4=,6-diamidino-2-phenylindole (DAPI) staining (Fig. 6A). Quantification of intracellular
FIG 5 Phenotype of ZIKV lacking the ability to generate sfRNAs in human and mosquito cells (A and B)
Differential requirement of sfRNA generation for ZIKV replication in the two hosts. Luciferase expression
levels of ZIKVAr-R WT and ΔSLI-II are shown as a function of time in Huh-7 and C6/36 cells. The luciferase
values shown are means  standard deviations from a representative experiment (three independent
experiments were performed). (C) (Left) immunofluorescence showing ZIKV antigen positivity in C6/36
cells transfected with ZIKVAr WT and ZIKVAr ΔSLI-II. (Right) The WT and mutant virus produced high-titer
stocks, as measured by focus-forming units (FFU) in C6/36 cells. (D) Representative images from
immunofluorescence assays showing ZIKV antigen positivity in human A549 and Dicer-competent U4.4
mosquito cells infected with ZIKVAr WT or ZIKVAr ΔSLI-II.
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FIG 6 Accumulation of ZIKV sfRNAs is essential for productive infection in human cells. (A) ZIKVAr ΔSLI-II infection is
quickly cleared in A549 cells. Immunofluorescence shows ZIKV antigen positivity and DAPI staining in A549 cells
infected at an MOI of 10 with WT or mutant ΔSLI-II virus. Cytopathic effect was observed with the WT virus at 72 hpi.
(B) ZIKV RNA genome accumulation as a function of time assessed by RT-qPCR for the WT and mutant as indicated.
(C) Northern blot showing the appearance of sfRNAs as a function of time from 2 to 24 h after infection of A549 cells
with WT virus. RNA markers are shown on the left, and sfRNAs are indicated on the right. (D) Induction of cytokines
produced in A549 cells infected with ZIKVAr WT or ZIKVAr ΔSLI-II under the same conditions as for panel A. IFN-,
TNF-, and IL-6 mRNAs were evaluated by RT-qPCR and are expressed as fold induction with respect to the
noninfected control and relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Shown are the
means with SD of two replicates. Statistics were performed with an unpaired t test, with P values represented as
follows: *, P  0.05; **, P  0.01; ***, P  0.001; and ns, not significant. (E) Induction of ISG in ZIKVAr WT- or ZIKVAr
ΔSLI-II-infected cells. MxA, OAS-1, ISG-15, and IRF-7 mRNAs were evaluated by RT-qPCR and expressed as fold
induction with respect to the control and relative to GAPDH mRNA. Shown are the means with SD of two replicates;
statistics were performed as described for panel D. (F) STAT2 is efficiently degraded after 24 h of infection with WT
or mutant ΔSLI-II virus in A549 cells. Western blots show human STAT2, viral structural capsid protein, nonstructural
protein NS3, and GAPDH control.
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accumulation of the viral genome indicated that the mutant virus infected and repli-
cated, but the viral RNA levels were about 10-fold lower than for the WT (Fig. 6B).
Kinetics of sfRNA generation for the WT virus was also determined under these
conditions. This analysis indicated detectable sfRNA1 and sfRNA2 as early as 8 hpi, and
at later times, sfRNA3 was also detected (Fig. 6C).
Production of beta interferon (IFN-) and proinflammatory cytokines and IFN sig-
naling were evaluated during the first 24 h of infection. Induction of IFN- was more
than 10-fold higher for the WT than the mutant ZIKV, which correlated with higher
levels of viral replication. Induction of tumor necrosis factor alpha (TNF-) and inter-
leukin 6 (IL-6) was also higher in the WT infection (Fig. 6D). Although the WT virus
induced considerably higher levels of IFN, the sfRNA-deficient virus induced the same
or higher levels of MxA, OAS1, ISG15, and IRF-7 mRNAs, suggesting that this mutant has
a limitation in controlling IFN signaling (Fig. 6E).
Flaviviruses use diverse mechanisms to counteract the IFN signaling; some of them
are well-described processes, such as NS5-mediated STAT2 degradation (39, 40). Thus,
the uncontrolled induction of IFN-stimulated genes (ISGs) with the mutant virus could
be associated with reduced degradation of STAT2 as a result of lower levels of NS5. To
evaluate this possibility, viral proteins and STAT2 were assessed at 24 hpi. The accu-
mulation of structural and nonstructural viral proteins was lower in the cytoplasmic
extracts obtained from mutant infection than that for the WT; however, STAT2 levels
were almost undetectable in both infections, indicating efficient degradation of the
host protein by both viruses (Fig. 6F). These results provide evidence that the lack of
sfRNAs during infection of human cells leads to an antiviral response that clears the
virus. It is likely that early events after infection are triggered differentially by the
sfRNA-deficient and WT viruses, since at 8 hpi, a reduced viral genome accumulation of
the mutant was observed (Fig. 6B). Viral clearance could be explained by uncontrolled
IFN signaling or deregulation of ISG mRNAs translation, in addition to other early
intrinsic or innate responses. Further studies will be necessary to define the implication
of such early events.
In summary, our findings provide conclusive evidence of the need for sfRNAs for
ZIKV productive infection in human cells.
Generation of at least one sfRNA species is necessary for efficient infection and
transmission of ZIKV in Aedes aegypti mosquitoes. Natural mosquito infections with
different flaviviruses produce sfRNAs that modulate antiviral responses. However, the
role of these noncoding viral RNAs in mosquito infections is still unclear. To investigate
the requirement of different species of sfRNAs for infection and transmission in A.
aegypti, we used viral mutants deficient in generating different sfRNAs. Viral stocks of
recombinant ZIKVs that produce sfRNA1 and -2, only sfRNA2, or neither of them (ZIKV
WT, ZIKVΔSLI, ZIKVΔSLII, or ZIKVΔSLI-II) were generated in mosquito C6/36 cells.
Female A. aegypti mosquitoes were fed with an infectious blood meal containing 106
FFU/ml of ZIKV WT, ZIKVΔSLI, ZIKVΔSLII, or ZIKVΔSLI-II. At 14 days postfeeding, the
presence of the virus was evaluated in the body and saliva of individual mosquitoes. In
addition, RNA extracts of whole mosquitoes were used to assess the presence and
quality of sfRNAs by Northern blotting (Fig. 7A). The WT and the ΔSLI viruses showed
high infection rates, with more than 80% of the mosquitoes ZIKV positive in three
different experiments. In contrast, viruses lacking SLII or both SLs showed reduced
infections rates with respect to that of WT (about 50 and 30%, respectively [Fig. 7B]).
Saliva from mosquitoes was collected and used for viral amplification in cultured
mosquito cells. The presence of ZIKV was assessed in the supernatant of these cultures.
Using this protocol, more than 50% of the mosquitoes infected with WT or ΔSLI virus
showed viral presence in saliva. Viruses lacking sfRNAs also reached saliva but with
remarkable less efficiency, between 4% and 25% (Fig. 7B).
Mosquitoes that were positive for ZIKV infection were analyzed to study the quality
and amount of sfRNAs produced. Individual mosquitoes were used to extract total RNA
and subjected to Northern blot analysis (Fig. 7C). WT ZIKV accumulated similar amounts
of two species of sfRNAs and a small amount of a third species, also observed in cell
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culture infections, of about 250 nucleotides in length. ZIKVΔSLI produced mainly
sfRNA2. In mosquitoes infected with ZIKVΔSLII or ZIKVΔSLI-II, which were positive for
genomic viral RNA, no sfRNAs were detected, confirming a central role for SLII in sfRNA
formation.
We conclude that production of sfRNA1 is not required for ZIKV to complete a
successful transmission cycle. Importantly, production of at least one sfRNA is necessary
for efficient infection and transmission of ZIKV in A. aegypti mosquitoes.
DISCUSSION
In this study, we identified molecular requirements for ZIKV sfRNA generation,
providing new information about the relevance of different species of sfRNAs for
infecting human cells and A. aegypti mosquitoes. A complex interplay between differ-
ent RNA structures present at the viral 3= UTR for production of sfRNAs was found.
Importantly, we generated new recombinant ZIKVs incapable of producing sfRNAs that
were able to infect and propagate in mosquito cells. In contrast, the sfRNA-impaired
virus was rapidly cleared in human cells, demonstrating the essential role of sfRNAs in
counteracting antiviral responses in these cells. Interestingly, A. aegypti mosquito
FIG 7 At least one sfRNA is necessary for efficient ZIKV infection and transmission in A. aegypti
mosquitoes. (A) Schematic overview of experimental design. (B) Female A. aegypti mosquitoes were fed
with an infectious blood meal containing 1  106 FFU/ml of ZIKVAr WT or mutant viruses producing
different qualities of sfRNAs. Mutant ZIKVAr ΔSLI, ΔSLII, or ΔSLI-II was used as indicated. Engorged
females were incubated for 14 days at 28°C, and infection and transmission rates were determined by
viral genome RT-qPCR of whole body or saliva. Results from a representative experiment are shown.
Statistics were performed by Fisher’s exact test on cumulative data analyzing each condition in pairs. *,
P  0.05; **, P  0.01; ***, P  0.001. (C) ZIKV mutants produce different kinds of sfRNAs in infected A.
aegypti mosquitoes. Northern blots of RNA samples prepared from individual infected mosquitoes are
shown.
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infections using a battery of ZIKV mutants producing different kinds and amounts of
sfRNAs revealed that at least one species of sfRNA is sufficient for infection and
transmission, and viruses that did not produce sfRNAs infected mosquitoes inefficiently.
Finally, distinct spatial arrangement of ZIKV and DENV RNA structures at the viral 3= UTR
were defined, supporting specialization of RNA elements for viral infection, with
possible implications in virulence and viral transmission.
Important human flaviviruses, including DENV, YFV, ZIKV, and WNV, produce differ-
ent kinds of sfRNAs, with different lengths and amounts (15, 18–20). A plethora of
activities have been proposed for these molecules, and likely they play multiple roles
during infection. It has been reported that they suppress type I IFN response in
vertebrates, inhibit RNA interference (RNAi) and Toll pathways in insects, impair cellular
RNA turnover, and regulate cellular splicing (for review, see references 33 and 41).
Different studies have searched for the molecular targets of sfRNA in viral RNA sensing
and IFN response pathways. In this regard, binding of DENV sfRNAs to G3BP1, G3BP1,
and CAPRIN1 was proposed to modulate translation of ISGs (25). Also, sfRNA binding to
TRIM25 was reported to reduce viral sensing by RIG-I (32). More recently, it has been
reported that sfRNA binding to FMRP and DDX6 (ME31B in mosquitoes) could restrict
antiviral activities of these proteins (29, 31, 42, 43). Because flaviviruses infect a wide
range of hosts (humans, birds, bats, and insects, among others), sfRNAs should coun-
teract different types of antiviral responses or facilitate viral processes in different
environments. Thus, the distinct kinds of sfRNAs accumulated in flavivirus infections
likely fulfill virus-specific needs. Although an important body of work about molecular
determinants and functions of sfRNAs from different MBFVs has been generated, it is
necessary to understand the mechanisms, functions, and evolution of sfRNAs in each
virus.
Using recombinant ZIKV, we dissected requirements for sfRNA formation during
infection. WT ZIKV mainly accumulates sfRNA1 and sfRNA2. We found that sfRNA1
formation requires the integrity not only of SLI but also of SLII. Point mutations that
destabilize the SLII structure or deletion of this element impaired accumulation of both
sfRNA1 and sfRNA2, suggesting strong cooperativity between the two SLs. In this
regard, a recent study analyzed the conformation of complete sfRNAs from ZIKV by
small-angle X-ray scattering (SAXS) and computational modeling (44). This report
indicated that the region of the 3= UTR containing SLI and SLII (xrRNA1-2) forms
compact structures with reduced flexibility in solution, providing a structural basis for
the functional cooperativity observed in this study with recombinant ZIKVs. Impor-
tantly, previous functional studies using DENV and WNV have shown coupling between
the two SLs for sfRNA formation (20, 38). Using DENV, we have previously shown that
deletion of SLII reduces SLI activity. In this case, xrRNA1 was still active and a distinctive
pattern of sfRNAs was observed in infected cells (20, 45). In addition, infections with
recombinant WNV with SLIV deletion (analogous to SLII in DENV and ZIKV) reduced
function of the upstream SL and resulted in the accumulation of smaller sfRNAs (14, 19).
It is important to mention that in the case of ZIKV, the lack of SLII almost abolished
sfRNA accumulation, a property that was found to be unique for this virus (Fig. 4B).
Together, these studies highlight the conservation of high-order RNA structures in-
volved in sfRNA formation in different MBFVs. Of note, vaccine candidates for DENV and
ZIKV with deletions within the DB structures have been shown to produce lower levels
of sfRNAs, suggesting additional interactions between different regions of the 3= UTR,
in this case between SLs and DB elements (29, 46). RNA-RNA contacts between different
domains of the 3= UTR or interaction with proteins could facilitate the coupling
observed. Further structural and functional studies will be necessary to define the
nature of this cooperativity.
Our studies indicate that the two SL structures in the ZIKV genome diverged to
acquire distinct functions. Deletion or mutations of SLI or SLII have different impacts on
ZIKV replication (Fig. 3). Interestingly, opposite functions were found for the two SL
structures for ZIKV infections in mosquito cells (Fig. 3E). Similar opposed functions were
previously observed with DENV, but the SLs displayed an inverted location in the 3= UTR
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(Fig. 3) (36). While SLII of ZIKV and SLI of DENV acted as enhancers of infection, SLI of
ZIKV and SLII of DENV displayed strong inhibitory activity on viral RNA replication. In
this regard, we have previously reported that adaptation of DENV to mosquito cells or
competition experiments in infected Aedes mosquitoes led to positive selection of
mutations and deletions specifically within SLII. Increased viral fitness was observed
with cloned DENV variants adapted to mosquito with mutations in SLII (20). We have
previously suggested that a change in sfRNA patterns (due to SLII mutations) was the
cause of increased DENV replication in mosquitoes. Our data using ZIKV suggest that
changes in the sequences of SLI rather than alteration in sfRNAs could be the cause of
the increased viral fitness. In this regard, a ZIKV mutation in SLI (ZIKV5=mSLI) that alters
sfRNA pattern, similar to that observed with the SLI deletion mutant, does not increase
viral replication (Fig. 4E and G), suggesting that deletion of specific inhibitory se-
quences and not the accumulation of sfRNA2 may explain the phenotype observed.
It is intriguing why ZIKV and DENV have evolved functions of the SL structures in
inverted locations. We can speculate that a ZIKV with a similar SL arrangement as that
observed in the DENV 3= UTR will be less fit in nature. In this case, the ZIKV SLII would
be under selective pressure in mosquitoes, incorporating mutations that would impair
production of both sfRNAs (Fig. 4B) and reduce the viral ability to infect and be
transmitted by mosquitoes (Fig. 7). In contrast, in the ZIKV arrangement, if variations in
SLI are associated with mosquito adaptation, this virus will still accumulate large
amounts of sfRNA2 (Fig. 4B and E) for efficient infection and transmission (Fig. 7). In the
case of DENV, the natural 3= UTR arrangement is viable because mutations in SLII still
leads to accumulation of sfRNAs, maintaining high fitness in mosquitoes (20). Thus, SL
specialization in the two viruses could be under selective pressure to produce the
necessary amounts and kinds of sfRNAs for each virus. Our studies support distinct
functions of SLI and SLII in the two viruses, while maintaining, in both cases, SLII as a
central regulator for sfRNA generation.
ZIKVs lacking the ability to generate sfRNAs replicated and propagated efficiently in
mosquito cells, but infections were unproductive in human cells (Fig. 5A and B). This
indicates that by manipulating the viral 3= UTR it is possible to restrict replication to a
single host. Interestingly, infection of human cells with a ZIKV lacking sfRNA production
showed an unexpected phenotype. When a high multiplicity of infection (MOI) was
used, infection was observed by IF analysis; however, this was followed by a quick
elimination of the virus (Fig. 6A). It is likely that the cellular antiviral response controlled
the propagation of the sfRNA-deficient virus. The levels of IFN and proinflammatory
cytokines induced after infection correlated well with viral replication levels, which
were about 10-fold higher for the WT than the mutant virus (Fig. 6B and E). However,
the strong induction of ISGs observed with the sfRNA-deficient virus suggested a lack
of control of IFN signaling (Fig. 6E). It is unclear whether this is a main cause of virus
elimination. Additional intrinsic antiviral responses, controlled by sfRNAs in the WT, can
be also relevant in limiting infection with the mutant virus. Importantly, we demon-
strated for the first time an absolute requirement of sfRNAs for ZIKV propagation in
human cells. This is a unique property of ZIKV, because previous reports showed that
sfRNA-deficient flaviviruses, including WNV, YFV, and DENV, were able to sustain
productive infections in human cells (15, 20, 23).
In A. aegypti mosquitoes, we found that at least one sfRNA was necessary for high
infection and transmission rates. Viruses with deletions of SLII alone or in combination
with SLI were severely impaired. Northern blot analysis of individual mosquitoes
infected with these viruses indicated that in samples that were quantitative PCR (qPCR)
positive for viral genome, no sfRNAs were detected. In contrast, mosquitoes infected
with WT or ΔSLI virus accumulated sfRNA1 and sfRNA2 or only sfRNA2, respectively.
Interestingly, a recent report has demonstrated a role for ZIKV sfRNAs in binding host
antiviral proteins in mosquitoes (42). In that study, a ZIKV producing sfRNA2 but lacking
sfRNA1 was employed. Using this virus, a significant role was assigned to sfRNA1 for
infection and transmission. We found that a ZIKV producing only sfRNA2 (lacking
sfRNA1) showed efficient infection and transmission rates in A. aegypti. However,
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although the mutations used in this study and in the previous study produced only
sfRNA2, the recombinant viruses used carried different mutations in their 3= UTRs. It is
possible that the defect observed previously is due to the mutation introduced rather
than the lack of sfRNA1. Also, because deletion of SLI displays a replication advantage
in cell culture, we cannot rule out that sequences within SLI could be detrimental in
adult mosquitoes, which may be masked by additional roles of SLI in sfRNA accumu-
lation. Nevertheless, further studies will be necessary to dissect multiple functions of
these RNA structures in mosquito infections. We conclude that ZIKV impaired in sfRNA
formation displays strong defects in overcoming mosquito infection barriers, which is
essential for viral transmission.
In this work, we delivered new genetic tools to dissect ZIKV molecular biology and
defined functions of sfRNAs in viral infections in the two hosts. We believe that
dissecting the roles of viral RNA determinants of relevant flaviviruses will provide
opportunities for rational antiviral strategies.
MATERIALS AND METHODS
Ethics statement. Human blood used to feed mosquitoes was obtained from healthy volunteer
donors. Healthy donor recruitment was organized by local investigator assessment using medical history,
laboratory results, and clinical examinations. Biological samples were supplied through participation of
healthy volunteers at the ICAReB biobanking platform (BB-0033-00062/ICAReB platform/Institut Pasteur,
Paris/BBMRI AO203/[BIORESOURCE]) of the Institut Pasteur to the CoSImmGen and Diagmicoll protocols
which have been approved by the French Ethical Committee (CPP) Ile-de-France I. The Diagmicoll
protocols were declared to the French Research Ministry under reference no. DC 2008 – 68 COL 1.
Construction of ZIKV infectious clones. A clinical isolate of 2016 from Argentina, ARCB116141
(GenBank accession no. MK637519), obtained in the Maiztegui Institute (INEVH, Pergamino, Buenos Aires,
Argentina), and a lab-adapted virus from Senegal, A1C1/V2 (GenBank accession no. KX198134), were
used for full-genome sequencing and cDNA cloning. Viral isolates were grown in A549 human cells, and
RNA was purified from supernatants with TRIzol (Thermo Fisher Scientific) and reverse transcribed using
Moloney murine leukemia virus (M-MLV) reverse transcriptase (Promega). cDNA fragments were ampli-
fied by PCR and amplicons were sequenced using oligonucleotides spanning the complete ZIKV genome
(see Table S1 in the supplemental material). The 5= and 3= UTRs were sequenced by ligation of the 5= and
3= ends of the genome. For this end, viral RNA decapping using RNA 5= pyrophosphohydrolase (New
England BioLabs [NEB]) was followed by ligation with T4 RNA ligase (NEB). The RNA was reverse
transcribed and cDNA was amplified by PCR using the oligonucleotides AVG2137 (CCATGATCTGTATAT
AACACTTATTCATCCCCA) and AVG2008 (CTGAGTCAAAAAACCCCACGCG). For full-length ZIKV cDNA as-
sembly, six PCR amplicons were cloned into pBR322 as depicted in Fig. 1A. Cryptic E. coli promoters were
predicted with the publicly available software of the Berkeley Drosophila Genome Project, Softberry Inc.
Software, and the Genome2D web server. Putative promoters were disrupted by introducing synony-
mous changes. In addition, in order to facilitate assembly and reverse genetic studies, specific sites for
restriction enzymes were inserted or removed by synonymous substitutions. A modified T7 promoter
(5=-TAATACGACTCACTATAAG-3=) was inserted upstream of the viral sequence and a unique restriction
site was inserted at the 3= end for linearization and runoff transcription.
Construction of ZIKV reporter virus. In order to design a ZIKV reporter virus, we used a strategy
similar to the one previously reported for DENV (45). In brief, we inserted the Renilla luciferase gene
flanked by the autoproteolytic FMDV 2A peptide. At the N terminus of the polyprotein, the cis-acting
elements for genome replication present in the capsid coding sequence were duplicated, followed by the
luciferase gene and the complete viral ORF. The cDNA clones from the two reporter systems were fully
sequenced.
RNA transcription and transfection and viral infection. Plasmids containing the full-length
sequences of the epidemic and nonepidemic isolates, pZIKVAr and pZIKVSe, were linearized with KpnI
and SacII, respectively, and used for in vitro transcription using T7 RNA polymerase (Ambion) in the
presence of m7GpppA cap analog (NEB). RNA quantification was assessed using a Qubit4 (Invitrogen)
and RNA integrity was confirmed on 1% agarose gels. RNA transcripts were transfected into C6/36HT and
A549 cells using Lipofectamine 2000 and Opti-MEM media (Invitrogen). Viruses were harvested as a
function of time. To generate viral stocks, C6/36HT cells were used.
Cell culture. ZIKV infections were performed using the following cell lines. C6/36HT cells (ATCC
CRL-1660), an Aedes albopictus cell line adapted to grow at 33°C, and U4.4 cells (A. albopictus) were
cultured in Leibovitz’s L-15 medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml of
penicillin, 100 g/ml of streptomycin, 0.3% tryptose phosphate broth, 0.02% glutamine, 1% minimal
essential medium (MEM) nonessential amino acid solution, and 0.25 g/ml of amphotericin B (Fungi-
zone). A549 cells (human epithelial lung cell line) were cultured in Dulbecco’s modified Eagle’s medium
with nutrient mixture F-12 (DMEM–F-12) supplemented with 10% fetal bovine serum, 100 U/ml of
penicillin, and 100 g/ml of streptomycin. Huh-7 cells (human hepatocyte cell line) were cultured in
Dulbecco’s modified Eagle’s high-glucose medium (4500 mg/liter) supplemented with 10% fetal bovine
serum, 100 U/ml of penicillin, and 100 g/ml of streptomycin.
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Recombinant ZIKVs. Mutations were introduced in the full-length cDNA of ZIKV ARCB116141
pZIKVAr, replacing the AgeI-KpnI fragment with the respective fragment derived from overlapping PCRs
containing the desired mutations using the oligonucleotides described in Table S1. The deletions were
designed as follows: ZIKVΔSLI lacked nucleotides 10399 to 10466, ZIKVΔSLII nucleotides 10482 to 10547,
and ZIKVΔSLI-II nucleotides 10399 to 10547. For recombinant reporter viruses, the mutations were
introduced in the context of the pZIKVAr-R using the same restriction enzymes and strategy as described
for pZIKVAr.
Immunofluorescence assays. C6/36HT or human A549 cells infected with WT or recombinant ZIKV
were grown in 24-well plates containing 1-cm2 coverslips. At various times posttransfection, coverslips
were removed, and cells were fixed with methanol for 15 min at –20°C. For detection of viral antigens,
a polyclonal anti-NS3 was used. Alexa Fluor 488-conjugated rabbit anti-mouse immunoglobulin G
(Molecular Probes) was employed to detect the primary antibody under the same conditions.
Viral titration. Viral titers were determined by plaque assays in BHK-21 cells or by colorimetric-based
focus forming units (FFU) in C6/36HT cells. For the latter, cells were prepared in 24-well plates, infected
with serial 10-fold dilutions, and covered with a semisolid L-15 medium with 0.8% carboxymethyl
cellulose (Sigma-Aldrich). After incubation at 33°C for 8 to 9 days, medium was removed and cells were
fixed with 4% saccharose paraformaldehyde in phosphate-buffered saline (PBS) for 20 min at room
temperature and blocked in 250 l/well of B buffer (2.5% bovine serum, Internegocios; 0.1% Tween
20-PBS) at room temperature for 1 h. The blocking buffer was then replaced with 250 l/well of rabbit
polyclonal anti-NS3 antibody (1:500 in blocking buffer) for 1 h at room temperature. After being washed
three times with 0.1% Tween 20-PBS, the cells were subjected to alkaline phosphatase-conjugated goat
anti-rabbit IgG (Sigma; 1:500 in blocking buffer) for 1 h. For chromogenic development, we used 200
l/well of 5-bromo-4-chloro-3-indolylphosphate–nitroblue tetrazolium (BCIP-NBT) color development
substrate (Promega) according to the manufacturer’s instructions. Chromogenic development was
monitored at room temperature, and the reaction was stopped by rinsing twice with 200 ml/well of PBS.
RNA quantification. For qRT-PCR of viral RNA, total RNA samples were used for reverse transcription
as previously described (47). Reactions were performed in duplicates in 96-well plates using 2 l of the
RT reaction mixture as the template, 5 l of FastStart SYBR green Master 2 mix (Roche), a 300 nM
concentration of each primer, and RNase-free water to 10 l. The primers AVG1117 (5=-ACAAGTCGAAC
AACCTGGTCCAT-3=) and AVG1118 (5=-GCCGCACCATTGGTCTTCTC-3=) were targeted to amplify nucleo-
tides 9937 to 10113 within the NS5 coding sequence. For quantification of IFN-, TNF, IL-6, and ISGs,
qRT-PCR was used; the oligonucleotides employed are detailed in Table S1.
Viral RNA structure comparison and sequence alignments. RNA structure comparison was
performed using RNAforester, which estimates RNA structural similarities based on the tree alignment
model (48), and sequence alignments via the MUSCLE algorithm and UPGMA (unweighted pair group
method using average linkages) tree construction method.
Northern blot assay. For ZIKV sfRNA detection, total RNA was obtained using TRIzol from infected
cells and separated on 1% agarose, 2% formaldehyde, or 5% polyacrylamide 7 M urea gels. RNA was then
transferred onto a nylon membrane (Hybond-N; GE Healthcare) using a semidry blotting apparatus and
UV cross-linked. For detection of genomic RNA (gRNA), samples were loaded into a slot blot apparatus
using nylon membranes (Hybond-N; GE Healthcare). Then, membranes were blocked overnight (ON) at
68°C in DIG Easy Hyb granule (Sigma-Aldrich) hybridization solution. Uniformly digoxigenin-labeled RNA
probes were obtained by in vitro transcription using the DIG Northern starter kit (Sigma-Aldrich). Two
RNA probes were designed (i) for detecting genomic RNA that hybridize the 5= UTR and (ii) for detecting
both genomic RNA and sfRNAs that hybridize the 3= UTR. The 5= probe was complementary to
nucleotides 1 to 483 of the viral genome, and the 3= probe was complementary to the complete 3= UTR
(nucleotides 10373 to 10807). Northern blots were visualized with the ImageQuant LAS 4000 (GE
Healthcare Life Sciences). For detection of sfRNAs in A. aegypti mosquitoes, RNAs from individual
mosquitoes were obtained by TRIzol extraction and processed as the samples obtained from cell culture.
Mosquitoes. Experiments were performed with A. aegypti female mosquitoes belonging to the 17th
generation from wild mosquitoes collected in Kamphaeng Phet Province (Thailand). The insectary
conditions for mosquito maintenance were 28°C, 70% relative humidity, and a 12-h light and 12-h dark
cycle. Adults were maintained with permanent access to 10% sucrose solution.
Experimental ZIKV infections in vivo. Wild-type and recombinant ZIKVs that produce different
qualities of sfRNAs were obtained in mosquito C6/35 HT cells. For experimental mosquito infections, 6-
to 8-day-old female mosquitoes were deprived of sucrose for 24 h and transferred to a biosafety level 3
insectary. Washed rabbit erythrocytes resuspended in phosphate-buffered saline were mixed 2:1 with
prediluted viral stock and supplemented with 10 mM ATP (Sigma-Aldrich). The viral stock was prediluted
in Leibovitz’s L-15 medium with 10% FBS, 0.1% penicillin-streptomycin, and 1% sodium bicarbonate
(Gibco) to reach an infectious titer ranging from 5  106 to 1  107 focus-forming units per ml of blood
using a focus-forming assay in C6/36 cells as described above. A control blood meal was prepared
identically except that a supernatant of mock-inoculated cells replaced the viral suspension. Mosquitoes
fed on the infectious or control blood meal for 30 min through a membrane feeding system (Hemotek
Ltd.) set at 37°C with a piece of desalted pig intestine as the membrane. Following the blood meal, fully
engorged females were selected and incubated at 28°C and 70% relative humidity under a 12-h light and
12-h dark cycle with permanent access to 10% sucrose. After 14 days, mosquitos were used to evaluate
infection in the body and to evaluate virus in saliva. After removing legs and wings, mosquitoes were
salivated in a tip containing 20 l of FBS for 30 min. Mosquito saliva was amplified in C6/36 cells for
5 days. Total RNA from C6/36 cells and supernatants was extracted with the Quick-RNA Viral 96 kit (Zymo
Pallarés et al. Journal of Virology
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Research). Total RNA from body, legs, and wings was extracted using TRIzol reagent (Ambion) for viral
RNA detection.
Data availability. The sequence of the ZIKV isolate from Argentina (epidemic virus) is available in
GenBank under accession number MT636065.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
SUPPLEMENTAL FILE 1, XLSX file, 0.01 MB.
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